Chavy Arora
Datos Biográficos
| ID | 7990010 |
|---|---|
| NOMBRE | Chavy Arora |
| NOMBRES | Chavy |
| APELLIDO | Arora |
| FIRMA | ARORA C |
| AFILIACIONES | Wellcome Centre for Ethics and Humanities |
| VERIFICADO | No |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| OBRAS COMO AUTOR | 1 |
| OBRAS COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2022 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2022 |
| ÍNDICE H | 0 |
When is the use of suboptimal treatment in functionally untreatable multi-drug resistant tuberculosis morally permissible
Multidrug-resistant tuberculosis (MDR-TB) is well recognised as a serious threat to controlling and ending the TB epidemic. Treatment is time-intensive and costly. Current treatment guidelines recommend the use of at least four effective drugs plus pyrazinamide for a period of 18-24 months. There are, however, situations in which this is not feasible. This may be due to severe patterns of drug-resistance, poor tolerance to the medications, or sup…
Sin obras prominentes en esta página.
When is the use of suboptimal treatment in functionally untreatable multi-drug resistant tuberculosis morally permissible
Multidrug-resistant tuberculosis (MDR-TB) is well recognised as a serious threat to controlling and ending the TB epidemic. Treatment is time-intensive and costly. Current treatment guidelines recommend the use of at least four effective drugs plus pyrazinamide for a period of 18-24 months. There are, however, situations in which this is not feasible. This may be due to severe patterns of drug-resistance, poor tolerance to the medications, or sup…
Dilemma (1 obra) · Drug (1 obra) · Drug resistance (1 obra) · Ethics in medical practice (1 obra) · Extensively drug-resistant tuberculosis (1 obra) · Intensive care medicine (1 obra) · Interim (1 obra) · Limiting (1 obra) · Medicine (1 obra) · Mycobacterium tuberculosis (1 obra)